Paullone 2

Paullone 2

SCHEMBL30319785

N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 20/20 1.00
CCNB2 O95067 18/20 1.00
CDK1 P06493 18/20 1.00
CCNB1 P14635 18/20 1.00
CCNB3 Q8WWL7 18/20 1.00
CDK5 Q00535 16/20 1.00
CDK5R1 Q15078 16/20 1.00
CCNA2 P20248 5/20 1.00
CDK2 P24941 5/20 1.00
CCNA1 P78396 5/20 1.00
GSK3A P49840 5/20 0.82
CDK9 P50750 3/20 0.69
CCNT1 O60563 2/20 0.69
CDC7 O00311 2/20 0.69
PLK4 O00444 2/20 0.69
PDPK1 O15530 2/20 0.69
ROCK2 O75116 2/20 0.69
CHEK2 O96017 2/20 0.69
CCNE2 O96020 2/20 0.69
ABL1 P00519 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Paullone 2 SCHEMBL5688525 1.00 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL16085135 0.90 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL30319771 0.87 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL5688272 0.87 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL4017123 0.85 GSK3B (0.85) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL16085136 0.82 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
Cazpaullone SCHEMBL379127 0.82 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
Cazpaullone SCHEMBL29355820 0.82 GSK3B (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
Paullone SCHEMBL3178594 0.82 CCNB2 (1.00) GSK3BCCNB2CDK1CCNB1CCNB3
Paullone SCHEMBL29407267 0.82 CCNB2 (1.00) GSK3BCCNB2CDK1CCNB1CCNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115969814-A Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same 法斯瑞斯公司 2023-04-18 CN disclosed